Eppendorf Launches Move It Adjustable Spacing Pipettes for Synchronous Pipetting
Move It Adjustable Spacing Pipettes are a simple and safe solution for synchronous pipetting of a series of samples between different vessel formats.
Eppendorf introduced Move It Adjustable Spacing Pipettes for a simple and safe solution for synchronous pipetting of a series of samples between different vessel formats. Without tubing connections between the cone and piston-cylinder system, Move It reduces operating time and increases precision and durability without the need for several moving, fragile parts. Additionally, autoclavability is enabled, which escalates user and sample-safety.
"Our product engineers have developed a special design concept for a well-balanced and ergonomic pipette," said Peter Schmidt, business manager, Eppendorf, in an Aug. 12, 2020 company press release. "Further, the manual adjustment of the tip distance with the adjustment knob makes it possible to maintain this relaxed-ergonomic hand position even during format change.”
Source: Eppendorf
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
